Status: Not yet recruiting
Pilot Study Evaluating Catheter Directed Thrombolysis Device in Acute Intermediate Risk Pulmonary Embolism
This is a pilot study of the Flow Medical Catheter, a catheter-based device used to deliver clot-dissolving medication directly to a blood clot in the lungs (pulmonary embolism). The study evaluates whether the device can be used safely and as intended in adults with intermediate-risk acute pulmonary embolism. All participants receive treatment with the study device; there is no comparison group.
Participants needed: 20
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Flow Medical Solutions, Inc.Updated: Jul 2, 2026
Eligibility criteria
Age 18 to 75 years, inclusive. [+5]
High-risk (massive) PE: Sustained SBP <90 mmHg for ≥15 consecutive minutes, >40... [+48]